ES8501392A1 - Procedimiento para la obtencion de derivados de indol conteniendo azufre - Google Patents

Procedimiento para la obtencion de derivados de indol conteniendo azufre

Info

Publication number
ES8501392A1
ES8501392A1 ES526121A ES526121A ES8501392A1 ES 8501392 A1 ES8501392 A1 ES 8501392A1 ES 526121 A ES526121 A ES 526121A ES 526121 A ES526121 A ES 526121A ES 8501392 A1 ES8501392 A1 ES 8501392A1
Authority
ES
Spain
Prior art keywords
alkyl
indole derivatives
sulphuric
twice
substituted once
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES526121A
Other languages
English (en)
Other versions
ES526121A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of ES8501392A1 publication Critical patent/ES8501392A1/es
Publication of ES526121A0 publication Critical patent/ES526121A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE INDOL CONTENIENDO AZUFRE.CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA (III), PARA OBTENER UN INDOL DE FORMULA (I) Y SUS SALES DE ADICION DE ACIDO FISIOLOGICAMENTE ACEPTABLES. DONDE: IND SIGNIFICA UN RESTO INDOL-3-ILO QUE PUEDE ESTAR UNA O DOS VECES SUSTITUIDO POR ALQUILO, OH, HALOGENO Y OTROS; A SIGNIFICA UN RADICAL DE FORMULA (IV) O DE FORMULA (V); N SIGNIFICA 0 O 1; M ES 2, 3 O 4; E SIGNIFICA S, SO O SO2; AR SIGNIFICA UN GRUPO FENILO INSUSTITUIDO O UNA O DOS VECES SUSTITUIDO POR ALQUILO, OH, HALOGENO Y OTROS; X1 SIGNIFICA X O NH2; X SIGNIFICA HALOGENO Y; X2 Y X3 SIGNIFICAN NH, SI X1 ES NH2. LA REACCION SE EFECTUA EN UN AUTOCLAVE, EN PRESENCIA DE DISOLVENTES, COMO BENCENO, ACETONA, ALCOHOLES Y OTROS Y A TEMPERATURA ENTRE 0J Y 158JC.
ES526121A 1982-09-30 1983-09-29 Procedimiento para la obtencion de derivados de indol conteniendo azufre Granted ES526121A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823236243 DE3236243A1 (de) 1982-09-30 1982-09-30 Schwefelhaltige indolderivate

Publications (2)

Publication Number Publication Date
ES8501392A1 true ES8501392A1 (es) 1984-11-16
ES526121A0 ES526121A0 (es) 1984-11-16

Family

ID=6174592

Family Applications (1)

Application Number Title Priority Date Filing Date
ES526121A Granted ES526121A0 (es) 1982-09-30 1983-09-29 Procedimiento para la obtencion de derivados de indol conteniendo azufre

Country Status (14)

Country Link
US (1) US4617309A (es)
EP (1) EP0105397B1 (es)
JP (1) JPS5982384A (es)
AT (1) ATE20747T1 (es)
AU (1) AU564169B2 (es)
CA (1) CA1244831A (es)
DE (2) DE3236243A1 (es)
ES (1) ES526121A0 (es)
HK (1) HK28487A (es)
HU (1) HU192243B (es)
IE (1) IE56051B1 (es)
IL (1) IL69821A (es)
SG (1) SG94086G (es)
ZA (1) ZA837311B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342632A1 (de) * 1983-11-25 1985-06-05 Merck Patent Gmbh, 6100 Darmstadt Indolderivate
US4704390A (en) * 1986-02-13 1987-11-03 Warner-Lambert Company Phenyl and heterocyclic tetrahydropyridyl alkoxy-benzheterocyclic compounds as antipsychotic agents
DE3604949A1 (de) * 1986-02-17 1987-08-20 Merck Patent Gmbh Hydroxyindolester
DE3907974A1 (de) * 1989-03-11 1990-09-13 Merck Patent Gmbh Indolderivate
US5198443A (en) * 1991-06-28 1993-03-30 Warner-Lambert Company Substituted 1,2,3,6-tetrahydropyridines as central nervous system agents
US5120748A (en) * 1991-06-28 1992-06-09 Warner-Lambert Company Substituted 1,2,3,6-tetrahydropyridines as central nervous system agents
US5364767A (en) * 1993-02-11 1994-11-15 Research Organics, In. Chromogenic compounds and methods of using same
US7423176B2 (en) * 2004-04-13 2008-09-09 Cephalon, Inc. Bicyclic aromatic sulfinyl derivatives
US7119214B2 (en) * 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
EP1589016A1 (en) * 2004-04-13 2005-10-26 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
TW200734313A (en) 2006-01-17 2007-09-16 Astrazeneca Ab Piperazines and piperidines as mGluR5 potentiators
FR2932481B1 (fr) * 2008-06-13 2010-10-08 Sanofi Aventis Derives de 4-{2-°4-phenyl-3,6-dihydro-2h-pyridin-1-yl!-2- oxo-alkyl}-1-piperazin-2-one, leur preparation et leur application en therapeutique.
FR2932482B1 (fr) * 2008-06-13 2010-10-08 Sanofi Aventis Nouveaux derives de (phenyl-3,6-dihydro-2h-pyridinyl)- (piperazinyl ponte)-1-alcanone et leur utilisation comme inhibiteurs de p75
EP2606894A1 (en) 2011-12-20 2013-06-26 Sanofi Novel therapeutic use of p75 receptor antagonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2580475A (en) * 1947-10-30 1952-01-01 Schering Corp Imidazolinylalkyl ethers of pyridylcarbinols
GB1189064A (en) * 1967-05-01 1970-04-22 Sterling Drug Inc Indole Derivatives
DE2060816C3 (de) * 1970-12-10 1980-09-04 Merck Patent Gmbh, 6100 Darmstadt 4-Phenylpiperidinderivate Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen enthaltend diese Verbindungen
US4302589A (en) * 1980-05-08 1981-11-24 American Cyanamid Company Cis-mono and disubstituted-2-methyl-3-[(piperazinyl) and (piperidino)ethyl]indolines, intermediates for their preparation and methods of preparation
DE3034005C2 (de) * 1980-09-10 1982-12-09 A. Nattermann & Cie GmbH, 5000 Köln Indolessigsäure-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
ATE20747T1 (de) 1986-08-15
JPS5982384A (ja) 1984-05-12
HU192243B (en) 1987-05-28
HK28487A (en) 1987-04-16
IL69821A (en) 1986-09-30
AU564169B2 (en) 1987-08-06
SG94086G (en) 1989-01-27
IL69821A0 (en) 1983-12-30
HUT34970A (en) 1985-05-28
ZA837311B (en) 1984-06-27
AU1977783A (en) 1984-04-05
IE832311L (en) 1984-03-30
ES526121A0 (es) 1984-11-16
DE3236243A1 (de) 1984-04-05
EP0105397B1 (de) 1986-07-16
DE3364527D1 (de) 1986-08-21
IE56051B1 (en) 1991-03-27
US4617309A (en) 1986-10-14
EP0105397A1 (de) 1984-04-18
CA1244831A (en) 1988-11-15

Similar Documents

Publication Publication Date Title
ES8501392A1 (es) Procedimiento para la obtencion de derivados de indol conteniendo azufre
ES2000181A6 (es) Procedimiento para la obtencion de derivados de indol
ES8504786A1 (es) Procedimiento para la obtencion de derivados de indol
ES457001A1 (es) Un procedimiento de preparacion de derivados de fenetilamina.
ES8502108A1 (es) Procedimiento para la obtencion de derivados de tetrahidrocarbazol
NZ506853A (en) C11 oxymyl and hydroxylamino prostaglandins (PGF) analogs useful as medicaments
ES8801619A1 (es) Procedimiento para la obtencion de n-6-metoxi-5(perfluoroal-quil)-1-naftoil-n-metilglicinas y sus analogos tionaftoili- cos
DE3268541D1 (en) Benzodioxane-imidazoline compounds, their preparation and use
AU565894B2 (en) Indole derivatives
EP0157626A3 (en) Anti-diarrhoeal agents
JPS5414961A (en) Novel 3-hydroxyazetidine-3-carboxylic derivative
JPS5430186A (en) 2-morpholinomethyl-5-phenyloxazoles and their pharmaceutically permissible acid addition salt
JPS5436252A (en) Novel propano-anthracene derivatives and their preparation
JPS5430141A (en) Novel benzoylphenoxyacetic acid derivatives